期刊俱乐部:基于四维血流MRI的脾血流指数预测肝硬化相关脾功能亢进
研究纳入39例肝硬化门脉高压患者,行4D flow MRI和3-T MRI,在29例推导组中构建结合脾体积与血流的脾血流指数,并在10例验证组中以ROC分析评估其识别血小板<50×10³/μL或白细胞<3.0×10³/μL的能力;该指数预测重度脾功能亢进的敏感度和特异度均为100%。
要点
- 脾血流指数结合脾体积与血流,与血小板、白细胞及脾功能亢进严重程度的相关系数分别为ρ=-0.75、-0.48、-0.75(p≤0.001)。
- 验证组中脾血流指数预测重度脾功能亢进(血小板<50×10³/μL或白细胞<3.0×10³/μL)的敏感度100%、特异度100%。
- 推导组中脾体积、动脉血流、静脉血流及分流门脉血流百分比均与血小板计数呈负相关(ρ=-0.68、-0.68、-0.56、-0.36,p<0.05)。
核心结论
- 结合脾体积与血流的脾血流指数是比单独脾体积更好的脾功能亢进指标。
研究设计与样本
- 单中心研究,共39例肝硬化门脉高压患者(14女25男,平均年龄52±10岁),行4D flow MRI和3-T MRI(增强前后),推导组29例连续患者,验证组10例连续患者。
诊断标准与关键数值
- 脾血流指数预测重度脾功能亢进(血小板<50×10³ cells/μL或白细胞<3.0×10³ cells/μL)的敏感度100%、特异度100%;推导组中脾血流指数与血小板、白细胞及脾功能亢进严重程度的相关系数分别为ρ=-0.75、-0.48、-0.75(p≤0.001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The objective of this study is to evaluate the ability of spleen volume, blood flow, and an index incorporating multiple measures to predict cirrhosis-associated hypersplenism.
MATERIALS AND METHODS: A total of 39 patients (14 women and 25 men; mean [± SD] age, 52 ± 10 years) with cirrhosis and sequelae of portal hypertension underwent 4D flow MRI and anatomic 3-T MRI performed before and after contrast administration. Unenhanced 4D flow MRI was used to assess abdominal hemodynamics, and splenic volumes were measured on T1-weighted gradient-recalled echo MRI. Relationships among demographic characteristics, blood component counts, splenic volume, arterial flow, venous flow, and the percentage of shunted portal flow were assessed in 29 consecutive patients (i.e., the derivation group), to develop a splenic flow index. This index was assessed along with splenic volume and blood flow alone in 10 additional consecutive patients (i.e., the validation group) via ROC curve analysis, to identify platelet counts of less than 50 × 103 cells/μL, leukocyte counts of less than 3.0 × 103 cells/μL, or both.
RESULTS: In the derivation cohort (platelet count, 129 ± 76 × 103 cells/μL), splenic volume, arterial flow, venous flow, and the percentage of shunted portal flow were inversely correlated with platelet counts (ρ = -0.68, -0.68, -0.56, and -0.36, respectively; p < 0.05). Adding splenic volume to arterial flow and the product of venous flow and the percentage of shunted portal flow indexed to the body surface area yielded superior correlations with platelet counts, leukocyte counts, and the degree of severity of hypersplenism (ρ = -0.75, -0.48, and -0.75, respectively; p ≤ 0.001) and predicted severe hypersplenism (sensitivity, 100%; specificity, 100%) in the validation cohort (platelet count, 93 ± 71 × 103 cells/μL).
CONCLUSION: A splenic flow index that incorporates both splenic volume and blood flow is a better indicator of hypersplenism than is splenic volume alone.
引用
- Keller EJ, Kulik L, Stankovic Z, et al. JOURNAL CLUB: Four-Dimensional Flow MRI-Based Splenic Flow Index for Predicting Cirrhosis-Associated Hypersplenism. AJR Am J Roentgenol. 2017. PMID: 28463524. doi:10.2214/AJR.16.17620
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。